| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a89f8dab024e02ae765d1273e716f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80caec2bc7af3ece43d1889e41adb9d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1df0ef8cda5dc4c259c961c98f9a89c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5a0da73d29a1e7e3a9ccfa38885586 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2009-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d5a06d7a96a9a30a5fafbead6df95d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d32bd775d7db693b0ee3024841c9779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5887717bcae1130ae255face2ab1ce1 |
| publicationDate |
2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8642728-B2 |
| titleOfInvention |
Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| abstract |
This invention relates to the finding that collagen peptides bind to the osteoclast-associated receptor (OSCAR) and stimulate the activation and/or differentiation of OSCAR expressing cells, such as osteoclasts and osteoclast precursor cells. Collagen peptides are described which may be useful in the modulation of the differentiation and/or activation of OSCAR expressing cells, for example in the treatment of bone defects and disorders characterized by altered differentiation and/or activation of OS-CAR expressing cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021216916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020086758-A1 |
| priorityDate |
2008-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |